Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery CEACAM6

Path Created with Sketch.
Go to CEACAM6 Normal Tissue GalleryGo back to Product Page
Breast – CEACAM6 negative invasive breast cancer of no special type (NST).
Breast – CEACAM6 negative invasive breast cancer of no special type (NST).
Breast – CEACAM6 negative invasive breast cancer of no special type (NST). (2)
Breast – CEACAM6 negative invasive breast cancer of no special type (NST). (2)
Breast – CEACAM6 negative invasive lobular breast cancer.
Breast – CEACAM6 negative invasive lobular breast cancer.
Colon – Colorectal adenocarcinoma with faint apical membranous CEACAM6 staining of only few tumor cells while there is a strong CEACAM6 positivity of debris and inflammatory cells.
Colon – Colorectal adenocarcinoma with faint apical membranous CEACAM6 staining of only few tumor cells while there is a strong CEACAM6 positivity of debris and inflammatory cells.
Colon – Colorectal adenocarcinoma with intense membranous and cytoplasmic CEACAM6 staining of all tumor cells. .jpeg
Colon – Colorectal adenocarcinoma with intense membranous and cytoplasmic CEACAM6 staining of all tumor cells.
Colon – Colorectal adenocarcinoma with strong CEACAM6 staining of apical membranes of all tumor cells. .jpeg
Colon – Colorectal adenocarcinoma with strong CEACAM6 staining of apical membranes of all tumor cells.
Kidney – CEACAM6 negative clear cell carcinoma.
Kidney – CEACAM6 negative clear cell carcinoma.
Kidney – CEACAM6 negative oncocytoma.
Kidney – CEACAM6 negative oncocytoma.
Kidney – CEACAM6 negative papillary renal cell carcinoma.
Kidney – CEACAM6 negative papillary renal cell carcinoma.
Kidney – CEACAM6 negative papillary renal cell carcinoma. CEACAM6 positivity is largely limited to tumor associated inflammatory cells.
Kidney – CEACAM6 negative papillary renal cell carcinoma. CEACAM6 positivity is largely limited to tumor associated inflammatory cells.
Lung – Adenocarcinoma with intense membranous and cytoplasmic CEACAM6 staining of all tumor cells.
Lung – Adenocarcinoma with intense membranous and cytoplasmic CEACAM6 staining of all tumor cells.
Lung – Adenocarcinoma with moderate to strong CEACAM6 staining of apical membranes of most tumor cells.
Lung – Adenocarcinoma with moderate to strong CEACAM6 staining of apical membranes of most tumor cells.
Lung – CEACAM6 negative malignant mesothelioma (epitheloid). CEACAM6 positivity of intravascular inflammatory cells.
Lung – CEACAM6 negative malignant mesothelioma (epitheloid). CEACAM6 positivity of intravascular inflammatory cells.
Lung – CEACAM6 negative squamous cell carcinoma.
Lung – CEACAM6 negative squamous cell carcinoma.
Lung – Squamous cell carcinoma with strong, predominantly membranous CEACAM6 staining of a subset of tumor cells. CEACAM6 positivity occurs in maturing and keratinizing tumor cells.
Lung – Squamous cell carcinoma with strong, predominantly membranous CEACAM6 staining of a subset of tumor cells. CEACAM6 positivity occurs in maturing and keratinizing tumor cells.
Oral cavity – CEACAM6 negative squamous cell carcinoma.
Oral cavity – CEACAM6 negative squamous cell carcinoma.
Ovary – CEACAM6 negative clear cell carcinoma.
Ovary – CEACAM6 negative clear cell carcinoma.
Ovary – CEACAM6 negative endometroid carcinoma. Strong CEACAM6 positivity of tumor associated inflammatory cells.
Ovary – CEACAM6 negative endometroid carcinoma. Strong CEACAM6 positivity of tumor associated inflammatory cells.
Ovary – CEACAM6 negative serous high-grade carcinoma.
Ovary – CEACAM6 negative serous high-grade carcinoma.
Pharynx – Squamous cell carcinoma with membranous CEACAM6 positivity of only few tumor cells. CEACAM6 positivity is largely limited to tumor associated inflammatory cells.
Pharynx – Squamous cell carcinoma with membranous CEACAM6 positivity of only few tumor cells. CEACAM6 positivity is largely limited to tumor associated inflammatory cells.
Prostate – CEACAM6 negative adenocarcinoma (Gleason 3+3=6)
Prostate – CEACAM6 negative adenocarcinoma (Gleason 3+3=6)
Prostate – CEACAM6 negative adenocarcinoma (Gleason 4+4=8)_
Prostate – CEACAM6 negative adenocarcinoma (Gleason 4+4=8)_
Testis – CEACAM6 negative seminoma_.jpeg
Testis – CEACAM6 negative seminoma_
Thyroid – CEACAM6 negative papillary carcinoma. Strong CEACAM6 positivity of tumor associated inflammatory cells.
Thyroid – CEACAM6 negative papillary carcinoma. Strong CEACAM6 positivity of tumor associated inflammatory cells.
Urinary bladder – CEACAM6 negative non-invasive papillary urothelial carcinoma (pTa). .jpeg
Urinary bladder – CEACAM6 negative non-invasive papillary urothelial carcinoma (pTa).
Urinary bladder – Muscle-invasive urothelial carcinoma with strong CEACAM6 staining of most tumor cells_.jpeg
Urinary bladder – Muscle-invasive urothelial carcinoma with strong CEACAM6 staining of most tumor cells_
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2026 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors